Joseph Thornton, MD
Colon & Rectal Surgery · Las Vegas, NVNPI 1538147251
Payments from drug & device makers
What this record shows
Medtronic accounts for 77.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $3,244 and has fallen 99.5% since, to $17 in 2025.
Across 53 payments — averaging $97.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Johnson & Johnson$258
- Foundation Medicine, Inc.$148
- Takeda Pharmaceuticals U.S.A., Inc.$144
- Intuitive Surgical$118
- Mallinckrodt Hospital Products Inc.$117
- plus $403 from 9 others
Across 6 payments — averaging $607.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$4K
What the payments were for
- Speaking & faculty fees$2,50048%
- Food & beverage$2,69452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $4,005 |
| Johnson & Johnson | 3 | $258 |
| Foundation Medicine, Inc. | 1 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $144 |
| Intuitive Surgical | 1 | $118 |
| Mallinckrodt Hospital Products Inc. | 1 | $117 |
| Covidien LP | 1 | $109 |
| Tactile Systems Technology Inc | 1 | $107 |
| Dilon Technologies, Inc. | 1 | $37 |
| Axonics, Inc. | 2 | $34 |
| Alfasigma USA, Inc. | 1 | $31 |
| Boston Scientific | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$3,128
- FOUNDATIONONE$148
- FOUNDATIONONE HEME$148
- FOUNDATIONONE CDX$148
- FOUNDATIONFOCUS$148
- FOUNDATIONONE LIQUID CDX$148
- ECHELON ENDOPATH$132
- Da Vinci Surgical System$118
- OFIRMEV$117
- GATTEX$111
- Flexitouch Plus$107
- Entre Plus$107
How this compares
Too few colon & rectal surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 51 | $711 |
| Dicyclomine Hcl | 13 | $126 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Las Vegas
- Garrett FriedmanLas Vegas$1.2M
- Roger HsiungLas Vegas$44K
- Ren Yu ZhangLas Vegas$8K
- Ketan ThankiLas Vegas$7K
- Calvin LyonsLas Vegas$6K
- Melissa MilesLas Vegas$5K
- Lance HornerLas Vegas$5K
- Katherine SpechtLas Vegas$4K
- Stephanie WishnevLas Vegas$829
- Kent SasseReno$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.